Though advanced therapy medicinal products (ATMPs) hold great promise, finding the best way to exploit the technology has proved a challenge. Here, Biopharma Excellence’s Christian K Schneider outlines five development strategies to increase the likelihood of success.

Join our webinar with Altasciences to learn the key advantages and differences of conducting early phase clinical trials in North America versus other geographic regions.

The US Food and Drug Administration (FDA) issued an emergency use authorisation for AstraZeneca’s Evusheld for the pre-exposure prophylaxis of COVID-19.

Scientists found digital pill systems to be a 98 percent accurate intervention to help men adhere to pre-exposure prophylaxis (PrEP) regimens.

AstraZeneca has entered into a new global development and commercialisation agreement with Ionis Pharmaceuticals for eplontersen.